These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1304330)

  • 21. GM1 and ERK signaling in the aged brain.
    Mo L; Ren Q; Duchemin AM; Neff NH; Hadjiconstantinou M
    Brain Res; 2005 Aug; 1054(2):125-34. PubMed ID: 16084500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acetylcholine release in vivo: effects of chronic treatment with monosialoganglioside GM1.
    Maysinger D; Herrera-Marschitz M; Ungerstedt U; Cuello AC
    Neuropharmacology; 1990 Feb; 29(2):151-9. PubMed ID: 2330073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incorporation and metabolism of exogenous GM1 ganglioside in rat liver.
    Ghidoni R; Trinchera M; Venerando B; Fiorilli A; Sonnino S; Tettamanti G
    Biochem J; 1986 Jul; 237(1):147-55. PubMed ID: 3800874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monosialoganglioside cotreatment prevents haloperidol treatment-associated loss of cholinergic enzymes in rat brain.
    Mahadik SP; Mukherjee S
    Biol Psychiatry; 1995 Aug; 38(4):246-54. PubMed ID: 8547447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The metabolism of radiolabelled GM1-ganglioside in cultured skin fibroblasts from controls and patients with GM1-gangliosidosis].
    Inui K
    Nihon Rinsho; 1995 Dec; 53(12):3102-4. PubMed ID: 8577066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GM1 ganglioside protects nucleus basalis from excitotoxin damage: reduced cortical cholinergic losses and animal mortality.
    Mahadik SP; Vilim F; Korenovsky A; Karpiak SE
    J Neurosci Res; 1988 Aug; 20(4):479-83. PubMed ID: 3184210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of GM1 ganglioside on neonatally neurotoxin induced degeneration of serotonin neurons in the rat brain.
    Jonsson G; Gorio A; Hallman H; Janigro D; Kojima H; Zanoni R
    Brain Res; 1984 Nov; 318(2):171-80. PubMed ID: 6093923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LIGA20, a lyso derivative of ganglioside GM1, given orally after cortical thrombosis reduces infarct size and associated cognition deficit.
    Kharlamov A; Zivkovic I; Polo A; Armstrong DM; Costa E; Guidotti A
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6303-7. PubMed ID: 8022776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Siagoside. GM1, Sygen.
    Drugs R D; 1999 Jan; 1(1):36-7. PubMed ID: 10565981
    [No Abstract]   [Full Text] [Related]  

  • 30. Design and characterization of liposomes containing long-chain N-acylPEs for brain delivery: penetration of liposomes incorporating GM1 into the rat brain.
    Mora M; Sagristá ML; Trombetta D; Bonina FP; De Pasquale A; Saija A
    Pharm Res; 2002 Oct; 19(10):1430-8. PubMed ID: 12425459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ganglioside GM1 treatment prevents the effects of subacute exposure to toluene on N-[3H]propylnorapomorphine binding characteristics in rat striatal membranes.
    von Euler G; Fuxe K; Agnati LF; Hansson T; Gustafsson JA
    Neurosci Lett; 1987 Nov; 82(2):181-4. PubMed ID: 3696491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trial of ganglioside GM1 in acute stroke.
    Hoffbrand BI; Bingley PJ; Oppenheimer SM; Sheldon CD
    J Neurol Neurosurg Psychiatry; 1988 Sep; 51(9):1213-4. PubMed ID: 3066849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.
    Stojanov K; Georgieva JV; Brinkhuis RP; van Hest JC; Rutjes FP; Dierckx RA; de Vries EF; Zuhorn IS
    Mol Pharm; 2012 Jun; 9(6):1620-7. PubMed ID: 22536790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Approaches in the study of ganglioside metabolism.
    Tettamanti G; Ghidoni R; Sonnino S; Chigorno V; Venerando B; Giuliani A; Fiorilli A
    Adv Exp Med Biol; 1984; 174():273-84. PubMed ID: 6377848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-inflammatory action of AGF44, a ganglioside ester derivative.
    Amico-Roxas M; Caruso A; Cutuli VM; Scapagnini U; Morandi A
    Drugs Exp Clin Res; 1992; 18(6):251-9. PubMed ID: 1478165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formation of tritium-labeled polysialylated gangliosides in the cytosol of rat cerebellar granule cells in culture following administration of [3H]GM1 ganglioside.
    Chigorno V; Valsecchi M; Sonnino S; Tettamanti G
    FEBS Lett; 1990 Dec; 277(1-2):164-6. PubMed ID: 2269348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formation of ganglioside GD1b-lactone in rat brain from intracisternally administered GD1b.
    Riboni L; Ghidoni R; Tettamanti G
    J Neurochem; 1989 May; 52(5):1401-6. PubMed ID: 2709011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing the plasma pharmacokinetics, tissue distribution, excretion and effects on cholesterol pharmacokinetics of a novel hydrophilic compound, FM-VP4, following administration to rats.
    Wasan KM; Peteherych KD; Najafi S; Zamfir C; Pritchard PH
    J Pharm Pharm Sci; 2001; 4(3):207-16. PubMed ID: 11737986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Precursor-product relationship between GM1 and GD1a biosynthesized from exogenous GM2 ganglioside in rat liver.
    Trinchera M; Ghidoni R
    J Biochem; 1990 Apr; 107(4):619-23. PubMed ID: 2358435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fuc-GM1 ganglioside mimics the receptor function of GM1 for cholera toxin.
    Masserini M; Freire E; Palestini P; Calappi E; Tettamanti G
    Biochemistry; 1992 Mar; 31(8):2422-6. PubMed ID: 1311601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.